Guiyang Xintian Pharmaceutical Co.,Ltd. (SHE:002873)
China · Delayed Price · Currency is CNY 7.59
-0.10 (-1.30%)
Nov 6, 2026, 11:55 AM CST
SHE:002873 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 196.37 | 173.72 | 118.16 | 138.24 | 100.67 | 72.48 |
Trading Asset Securities | - | 0.1 | 0.12 | 0.09 | 0.11 | 80 |
Cash & Short-Term Investments | 196.37 | 173.82 | 118.28 | 138.33 | 100.78 | 152.48 |
Cash Growth | 15.83% | 46.95% | -14.49% | 37.26% | -33.91% | -65.97% |
Accounts Receivable | 193.24 | 286.84 | 325.67 | 250.54 | 261.96 | 282.72 |
Other Receivables | 7.88 | 13.05 | 22.09 | 48.22 | 42.12 | 21.52 |
Receivables | 201.12 | 299.9 | 347.77 | 298.76 | 304.08 | 304.24 |
Inventory | 140.52 | 172.11 | 145.48 | 184.33 | 183.34 | 118.77 |
Other Current Assets | 12.65 | 5.21 | 5.28 | 15 | 22.44 | 11.34 |
Total Current Assets | 550.66 | 651.04 | 616.81 | 636.43 | 610.65 | 586.83 |
Property, Plant & Equipment | 705.24 | 693.38 | 708.83 | 706.3 | 593.75 | 463.94 |
Long-Term Investments | 530.34 | 530.34 | 412.07 | 383.27 | 461.57 | 312.5 |
Goodwill | 6.19 | 6.19 | - | - | - | - |
Other Intangible Assets | 101.46 | 108.62 | 108.96 | 83.52 | 86.1 | 87.51 |
Long-Term Deferred Tax Assets | 8.21 | 9.03 | 10.06 | 10.33 | 13.46 | 11.26 |
Long-Term Deferred Charges | 109.72 | 102.11 | 90.36 | 88.45 | 70.39 | 58.67 |
Other Long-Term Assets | 25.26 | 20.37 | 3.41 | 3.5 | 3.6 | 3.71 |
Total Assets | 2,037 | 2,121 | 1,951 | 1,912 | 1,840 | 1,524 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 54.54 | 68.59 | 83.36 | 105.08 | 95.67 | 64.89 |
Accrued Expenses | 30.14 | 52.56 | 48.91 | 31.8 | 39.71 | 53.85 |
Short-Term Debt | 65.44 | 95.88 | 306.24 | 366.93 | 317.37 | 268.34 |
Current Portion of Long-Term Debt | 238.48 | 143.01 | 20.8 | 26.03 | 5.01 | - |
Current Portion of Leases | - | 3.76 | 4.97 | 4.16 | 1.4 | - |
Current Income Taxes Payable | 17.29 | 0.12 | 0.03 | 0 | 2.29 | 4.72 |
Current Unearned Revenue | 3.31 | 0.37 | 0.52 | 1 | 13.86 | 15.36 |
Other Current Liabilities | 33.92 | 15.91 | 16.55 | 20.42 | 26.4 | 34.07 |
Total Current Liabilities | 443.12 | 380.2 | 481.38 | 555.42 | 501.69 | 441.23 |
Long-Term Debt | 239.65 | 420.77 | 221.4 | 195.54 | 156.68 | 154.79 |
Long-Term Leases | 4.38 | 5.48 | 6.77 | 9.35 | 5.72 | 6.65 |
Long-Term Unearned Revenue | 25.65 | 24.27 | 23.58 | 20.83 | 22.15 | 24.51 |
Long-Term Deferred Tax Liabilities | 33.4 | 33.59 | 22.11 | 16.72 | 27.99 | 3.38 |
Other Long-Term Liabilities | 0.49 | 0.52 | 0.55 | 0.59 | 3.36 | 3.42 |
Total Liabilities | 746.69 | 864.83 | 755.79 | 798.47 | 717.59 | 633.98 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 244.1 | 244.1 | 244.1 | 231.49 | 231.97 | 164.05 |
Additional Paid-In Capital | 286.05 | 282.35 | 282.35 | 179.72 | 187 | 220.67 |
Retained Earnings | 669.89 | 660.32 | 665.32 | 637.57 | 579.88 | 490.94 |
Treasury Stock | -54.43 | -75.3 | -75.3 | -9.54 | -17.61 | -27.81 |
Comprehensive Income & Other | 144.77 | 144.77 | 78.24 | 74.09 | 140.69 | 42.61 |
Total Common Equity | 1,290 | 1,256 | 1,195 | 1,113 | 1,122 | 890.44 |
Shareholders' Equity | 1,290 | 1,256 | 1,195 | 1,113 | 1,122 | 890.44 |
Total Liabilities & Equity | 2,037 | 2,121 | 1,951 | 1,912 | 1,840 | 1,524 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 547.95 | 668.9 | 560.18 | 602.01 | 486.17 | 429.79 |
Net Cash (Debt) | -351.58 | -495.09 | -441.9 | -463.68 | -385.39 | -277.31 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -1.53 | -2.10 | -2.01 | -1.90 | -1.58 | -1.13 |
Filing Date Shares Outstanding | 236.89 | 235.3 | 235.3 | 231.4 | 231.89 | 228.31 |
Total Common Shares Outstanding | 236.89 | 235.3 | 235.3 | 231.4 | 231.89 | 228.31 |
Working Capital | 107.54 | 270.84 | 135.43 | 81 | 108.96 | 145.59 |
Book Value Per Share | 5.45 | 5.34 | 5.08 | 4.81 | 4.84 | 3.90 |
Tangible Book Value | 1,183 | 1,141 | 1,086 | 1,030 | 1,036 | 802.93 |
Tangible Book Value Per Share | 4.99 | 4.85 | 4.61 | 4.45 | 4.47 | 3.52 |
Buildings | - | 627.56 | 628.65 | 639.78 | 369.03 | 327.11 |
Machinery | - | 179.29 | 177.35 | 167.14 | 121.47 | 92.52 |
Construction In Progress | - | 65.92 | 55.81 | 33.72 | 228.36 | 151.22 |